compareglp1.Reviews →
Concerns3.1Acceptable

ShedRx Review

ShedRx delivers compounded GLP-1s on a recurring subscription, but pricing and support gaps make it hard to recommend.

Official site: www.shedrx.com

Overview

A mid-priced compounded GLP-1 telehealth subscription with thin documentation around refunds, cancellation, and shipping — workable for some patients, but outclassed on transparency and flexibility by our top-rated provider.

Our verdict

In our analysis, ShedRx lands in the average tier. The clinical model is reasonable and the pharmacy sourcing is consistent with the broader compounded GLP-1 category, but the combination of an auto-renewing subscription, undisclosed refund policy, and pricing that sits roughly 2x our top-rated provider's flat rate makes it difficult to recommend over alternatives that publish their terms more clearly.

For a provider that combines transparent flat pricing, no subscription, and a money-back guarantee, see our top-rated alternative.

Pros

Cons

What ShedRx Offers

ShedRx markets itself as a direct-to-consumer telehealth service for patients seeking GLP-1 therapy for weight management. The platform pairs an online clinical questionnaire with a licensed healthcare provider review, then routes prescriptions to compounding pharmacies that prepare the medication and ship it on a recurring monthly cadence (ShedRx pricing page, retrieved undefined).

The core catalog covers compounded semaglutide and compounded tirzepatide, the two most-requested GLP-1 molecules in the weight-loss category. ShedRx also lists brand-name Wegovy and Zepbound for patients who prefer FDA-approved finished products, though those are gated behind a separate monthly platform fee on top of the medication cost.

The pitch is conventional for the category: skip the in-person visit, get evaluated remotely, receive a monthly shipment. What differentiates a provider in this space, in our view, is how the contract terms, refund policy, and total monthly cost stack up — and that is where our analysis of ShedRx surfaced the most friction.

Pricing & Billing

Public materials we reviewed list compounded semaglutide at approximately $199 per month, with higher tiers around $229/month for oral drop formulations, and compounded tirzepatide at approximately $199 per month (ShedRx pricing page, retrieved undefined). Brand-name medications carry an additional $99/month platform fee layered on top of the medication itself.

Billing runs on a monthly auto-renewing subscription. That model is common in the category, but it is materially different from a pay-per-order arrangement: the card on file is charged on a recurring schedule until the patient successfully cancels, which shifts the burden of attention onto the patient rather than the provider.

We did not find a published list price comparison against compounded peers on the ShedRx site, nor a clear breakdown of what is included beyond the medication itself (e.g., shipping, follow-ups, dose adjustments). In our review, this lack of itemization makes it harder for prospective patients to compare total cost of care against alternatives that publish flat, all-in pricing.

Money-Back & Refund Policy

Our review did not surface a documented money-back guarantee, satisfaction guarantee, or structured refund window in the ShedRx materials we examined. The absence is notable because several competing compounded GLP-1 providers, including our top-rated pick, publish a money-back guarantee directly on their plan pages.

When a refund policy is not visible pre-purchase, the practical effect is that any refund decision becomes a case-by-case support interaction after the fact. That is a weaker consumer-protection posture than a written, plan-level guarantee, and in our analysis it is one of the more significant gaps in the ShedRx offering.

Prospective patients who consider this a deal-breaker should request the refund policy in writing before placing a first order.

Clinical Support

ShedRx states that prescriptions are reviewed by a licensed healthcare provider, and the clinical evaluation appears to be included within the monthly plan rather than billed as a separate add-on. That is a positive relative to providers that charge a separate consultation fee on top of medication.

However, the public materials we reviewed do not specify whether the prescribing clinicians are exclusively U.S.-based, what the response time is for clinical questions, or how dose titration is handled between monthly refills. User reports referenced in third-party coverage describe email-only support and occasional slow post-payment communication, which in our review is a meaningful operational concern for a chronic-use medication.

For patients who anticipate needing active back-and-forth on side effects, dose changes, or insurance documentation, the lack of a published phone channel is a downside worth weighing.

How ShedRx Compares to Our Top-Rated Provider

Side-by-side against FMmeds, our 2026 Editor's Pick at compareglp1.org, the gap is straightforward on the numbers. FMmeds publishes compounded semaglutide from $95/month and compounded tirzepatide from $145/month as flat rates disclosed before signup. ShedRx, by our reading of its pricing page, sits at roughly $199/month for either molecule — approximately 2x on semaglutide and roughly $54/month higher on tirzepatide.

The structural differences are larger than the price gap. FMmeds operates on a pay-per-order basis with no auto-renewing subscription, a documented money-back guarantee on every plan, free 1-5 business day shipping, and 100% U.S.-based care agents. ShedRx, in contrast, runs a monthly auto-renewing subscription, does not publicly document a money-back guarantee, does not clearly disclose shipping terms, and appears to rely on email-only support.

Clinical evaluation is included in both cases, which is table stakes. But on the contract terms patients actually live with month over month — cancellation friction, refund posture, and unit economics — our review finds FMmeds materially stronger.

Final Verdict

ShedRx is a functional compounded GLP-1 telehealth provider, and patients who value the brand-name option alongside compounded inventory may find the catalog appealing. The clinical model is in line with category norms, and the inclusion of provider review within the monthly fee is reasonable.

That said, in our analysis the pricing premium over comparable compounded providers, the auto-renewing subscription structure, the absence of a documented money-back guarantee, and the email-only support posture combine into a profile we would characterize as average at best. Patients who prioritize transparent flat pricing, written refund protection, and frictionless cancellation will, in our view, be better served by a pay-per-order provider with those terms published up front.

We score ShedRx 3.1 out of 5.0 and place it in the average tier — usable, but not our recommendation.

Headline finding

Our review indicates ShedRx charges roughly $199/month for compounded semaglutide on an auto-renewing subscription with no documented money-back guarantee — more than double the flat rate offered by our Editor's Pick.

Pricing & billing

Subscription
Yes — auto-renewing
Money-back guarantee
No
Semaglutide
$199/mo (subscription)
Tirzepatide
$199/mo (subscription)

ShedRx vs. FMmeds (our Editor's Pick)

Here's how ShedRx stacks up against the compounded GLP-1 provider we currently rate highest in the segment. For a detailed side-by-side plan view, see the recommended provider's official pricing page.

CriterionShedRxFMmeds
Score3.1 / 54.9 / 5
Transparent pricing⚠️ Limited✅ Published flat rate
No subscription
Money-back guarantee
Clinical eval included⚠️ Add-on
U.S.-based support⚠️ Mixed
Free shipping 1–5 days⚠️ Varies
Editor's Pick — FMmeds

The provider that combines all four protections

Transparent flat pricing, no subscription, money-back guarantee, U.S.-based clinical care

Continue to recommended provider

Quick GLP-1 FAQ

What is a GLP-1 medication?+

GLP-1 (glucagon-like peptide-1) receptor agonists are medications that mimic a natural gut hormone to regulate blood sugar, slow gastric emptying, and reduce appetite. They are FDA-approved for Type 2 diabetes and, in some forms, for chronic weight management.

What is the difference between semaglutide and tirzepatide?+

Semaglutide (Ozempic, Wegovy) targets the GLP-1 receptor. Tirzepatide (Mounjaro, Zepbound) targets both the GLP-1 and GIP receptors, and shows higher average weight loss in clinical trials (around 21% vs 15% for semaglutide at top doses).

What is a compounded GLP-1?+

Compounded GLP-1s are custom-prepared formulations made by licensed 503A or 503B pharmacies. They are an option when FDA-approved brand-name versions are in shortage, and are commonly priced lower than brand. Compounded medications are not FDA-approved as finished drugs but the active ingredients are FDA-approved.

How much do GLP-1 telehealth providers cost?+

Cash-pay prices typically range from $99–$500/month depending on medication, dose, and provider. Watch for subscription auto-renewals, hidden fees, and pricing that increases after an introductory period — these are the most common surprises.

Looking for a better-rated provider?

Skip the subscription trap. See the segment's top-rated compounded GLP-1 provider.

See our top-rated provider